News about Global Pharma

Viatris Acquires Aculys Pharma, Secures Exclusive Rights to Pitolisant and Spydia in Japan

Viatris has completed the acquisition of Aculys Pharma, a clinical stage biopharmaceutical company focused on commercialising innovative treatments for neurological conditions.

Global Pharma | 16/10/2025 | By Dineshwori |  766

China Approves GSK's Shingrix for Shingles Prevention

The China National Medical Products Administration (NMPA) has approved GSK’s Shingrix (Recombinant Zoster Vaccine or RZV) for the prevention of shingles (herpes zoster) in adults aged 18 years and over who are at increased risk of shingles due to immunodeficiency or immunosuppression caused by known disease or therapy.

Global Pharma | 15/10/2025 | By Dineshwori |  504

EY Acquires Aqurance to Boost Lifesciences Transformation on Veeva

The acquisition of Aqurance aims to strengthen the EY organisation’s Veeva Centers of Excellence, expanding clinical, regulatory and commercial services capabilities for global pharma and biotech.

Global Pharma | 15/10/2025 | By Dineshwori |  323

EVOQ Therapeutics Receives USD 2 Million NIH Grant to Develop Therapies for Celiac Disease

The NIH award represents a significant endorsement of EVOQ's ground-breaking approach to harnessing the power of the immune system to treat and prevent autoimmune diseases.

Global Pharma | 14/10/2025 | By Dineshwori |  285

Integral Molecular Launches Ready Reporter Virus Kit for 10x Faster Virus Neutralisation Testing

RRVs work by instantaneous detection of viral entry using a fluorescence-based readout. This rapid, safe and simple assay enables automatable workflows that can be performed in a standard laboratory setting.

Global Pharma | 14/10/2025 | By Dineshwori |  132

Cumberland Pharmaceuticals Expands Vibativ Access Through Premier Group Purchasing Agreement

American specialty pharmaceutical company Cumberland Pharmaceuticals has announced that its potent antibiotic Vibativ (telavancin) has been added to a national group purchasing agreement with Premier, a leading US healthcare improvement company.

Global Pharma | 14/10/2025 | By Dineshwori |  245

South Korea's GC Biopharma Secures CMO Rights for Curevo's Shingles Vaccine

South Korean biopharmaceutical company GC Biopharma has signed a contract manufacturing agreement with Curevo Vaccine to produce amezosvatein (development name: CRV-101), a recombinant shingles vaccine currently under clinical development.

Global Pharma | 13/10/2025 | By Dineshwori |  302

Merck to Present New Data from HIV Treatment and Prevention Pipeline at European AIDS Conference 2025

The data to be presented span Merck’s broad HIV portfolio, including investigational therapies for both treatment and prevention. The presentations will feature new clinical results from Phase 1, 2, and 3 studies evaluating the efficacy, safety, and pharmacokinetics of the company’s next-generation antiviral candidates.

Global Pharma | 13/10/2025 | By Dineshwori |  296

Chugai Pharma concludes licence agreement with Roche for CT-388

Chugai Pharmaceutical has signed a licensing deal with F. Hoffmann-La Roche for CT-388, a long-acting GLP-1/GIP receptor agonist for obesity and type-II diabetes, granting Chugai exclusive development and marketing rights in Japan.

Global Pharma | 11/10/2025 | By Dineshwori |  631

Johnson & Johnson MedTech Launches CORE-VA Registry to Advance Ventricular Arrhythmia Care

Johnson & Johnson MedTech, in collaboration with the Heart Rhythm Clinical and Research Solutions, has unveiled a new initiative aimed at improving outcomes for patients with life-threatening heart rhythm disorders.

Global Pharma | 11/10/2025 | By Dineshwori |  268